FORM 6-K

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Report of Foreign Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934

September 24, 2004

Commission File Number: 001-12033

Nymox Pharmaceutical Corporation

9900 Cavendish Blvd., St. Laurent, QC, Canada, H4M 2V2

        Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F    X   Form 40-F  ___

        Indicate by check mark if the registrant is submitting Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(l): ___

        Indicate by check mark if the registrant is submitting Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ___

        Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes  ___ No    X  

        If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):

82-______________

The Company is providing a summary of the shares reported purchased by current directors and officers of the Company since the December 20, 2000 announcement of the director's and management's intention to purchase the Company's shares on the open market.

As of September 21, 2000, the following officers and directors have reported total purchases of Nymox Pharmaceutical Corporation stock amounting to 230,475 shares. They have sold no Nymox shares during that period.

Nymox Shares Purchased by Current Directors and Officers Since December 20, 2000

Michael
Sonnenreich 		Walter
von Wartburg 		Paul
Averback 		Hans
Black 		Jack
Gemmell 		Michael
Munzar
Shares Owned and Controlled                            
Total Holdings
12/20/2000 		      10,000     12,000     13,094,395     10,000     0     31,325  
Total Holdings
09/21/2004 		      91,650     82,000     13,115,395     30,000     12,725     56,425  
Total Sales since
12/20/2000 		      0     0     0     0     0     0  
Total Purchases since
12/20/2000 		      81,650     70,000     21,000     20,000     12,725     25,100  

 
Purchased since December 20, 2000    
          12/21/2000       5,000     20,000                  
          01/03/2001       5,000                      
          02/16/2001       10,000                      
          02/28/2001               1,500              
          03/04/2001                       175      
          03/23/2001               1,000              
          03/28/2001               500              
          04/10/2001                           2,600  
          04/18/2001               4,000              
          06/28/2001           10,000                  
          08/28/2001       5,000                      
          09/04/2001                       1,200      
          10/04/2001                       8,625      
          02/05/2002                       525      
          06/13/2002       10,000                      
          07/31/2002       5,000                      
          08/14/2002       1,650                      
          09/11/2002       1,000                      
          10/02/2002       3,000                      
          01/27/2003       1,000                      
          03/19/2003       1,000                      
          04/08/2003       2,000                      
                           
          04/16/2003       6,000                      
          05/07/2003       1,000                      
          05/30/2003       2,000                      
          06/11/2003       1,000                      
          08/19/2003                           2,000  
          08/21/2003               4,000              
          08/27/2003           10,000                  
          09/08/2003       2,000                     2,000  
          09/10/2003                           3,000  
          09/12/2003                           2,500  
          09/17/2003                           2,500  
          09/29/2003                           2,000  
          10/01/2003                           2,000  
          10/02/2003                           150  
          10/03/2003                           2,700  
          10/07/2003                           2,650  
          10/20/2003                           1,000  
          10/23/2003               10,000              
          10/28/2003                   8,000          
          11/05/2004                   2,000          
          01/26/2004       1,000                      
          02/20/2004       3,000                      
          03/02/2004                       2,200      
          03/10/2004       5,000                      
          04/29/2004           20,000                  
          05/04/2004       5,000                      
          06/08/2004       3,000             10,000          
          06/09/2004       1,000                      
          06/14/2004       1,000                      
          08/12/2004       1,000                      
          08/24/2004           10,000                  
Total       81,650     70,000     21,000     20,000     12,725     25,100  

SIGNATURES

        Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

      NYMOX PHARMACEUTICAL CORPORATION
            (Registrant)


 		 By:  /s/ Paul Averback
Paul Averback
President and Chief Executive Officer


Date: September 24, 2004